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Abstract
Background: The multidisciplinary approach in the management of Amyotrophic Lateral Sclerosis (ALS) has been
shown to provide superior care to devolved care, with better survival, improved quality of care, and quality of life.
Access to expert multidisciplinary management should be a standard for patients with ALS. This analysis explores
the patient journey from symptom onset and first engagement with health services, to the initial visit to a specialist
ALS Multidisciplinary Clinic (MDC) in Dublin, Ireland.
Methods: A retrospective exploratory multi-method study details the patient journey to the MDC. Data from
medical interviews and systematic chart review identifies interactions with the health services and key timelines
for thirty five new patients presenting with a diagnosis of ALS during a 6 month period in 2013.
Results: The time from first symptom to diagnosis was a mean of 16 months (median 13 months), with a mean
interval of 19 months (median 14.6) from first symptoms to arrival at the MDC. The majority of patients were seen
by a general practitioner, and subsequently by neurology services. There was an average of four contacts with
health services and 4.8 investigations/tests, prior to their first Clinic visit. On the first visit to the MDC patients are
linked into an integrated ‘system’ that can provide specialist care and link with voluntary, palliative and community
services as required.
Conclusions: Engagement with a multidisciplinary team has implications for service utilization and quality of
life of patients and their families. We have demonstrated that barriers exist that delay referral to specialist
services. Comprehensive data recording and collection, using multiple data sources can reconstruct the
timelines of the patient journey, which can in turn be used to identify pathways that can expedite early
referral to specialist services.
Keywords: Patient journey, Amyotrophic lateral sclerosis (ALS), Medical interview, Chart review,
Multidisciplinary clinic, Ireland
Background
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenera-
tive disease characterized by progressive degeneration of
motor neurons in the brain and spinal cord, and is con-
sidered to be one of the most devastating neurological
disorders in adults. Up to 50 % of patients with ALS
develop a degree of cognitive impairment [1]. There are
currently no effective disease modifying therapies for
ALS and 70 % of those affected die within three years
from symptom onset [2]. There are approximately 110
new cases of ALS in the Republic of Ireland each year,
and at least 80 % of these attend the National ALS Clinic
in Beaumont Hospital, Dublin [3].
A diagnosis of ALS is primarily based on the physi-
cian’s interpretation of clinical symptoms and signs,
and investigations to exclude other causes [4–6].The
wide range of presentations of ALS coupled with the
rapid clinical trajectory require a flexible approach to
clinical care that is best provided in an integrated
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multidisciplinary setting [7, 8]. Early diagnosis and
access to expert multidisciplinary management
should be available as standard for patients with
ALS. However, most studies document a delay of 12-
15 months from first symptom to diagnosis, and
many patients experience further delays prior to re-
ferral to specialist services. The purpose of this
study was to document and describe in detail the
patient journey from their first symptoms, and first
engagement with health services, to their initial visit
to the multidisciplinary clinic. The overall objective
was to identify possible barriers to accessing multi-
disciplinary care and highlight the complexity of the
referral trajectory.
Multidisciplinary care
Given the current lack of effective treatment options for
ALS, the aim of care is to maximise quality of life from
the time of diagnosis through to the end of life. A pallia-
tive approach to care, delivered through a multidisciplin-
ary team (MDT) holistically considers the physical,
psychological, social and spiritual aspects of the patient,
family and illness. Optimal palliative management
requires a strategy that integrates hospital-based
multidisciplinary care with community-based inter-
ventions [9]. The specialist multidisciplinary clinic is
more than a bounded spatial and functional entity. It
is representative of an approach to clinical manage-
ment, clinical practice and healthcare delivery. The
multidisciplinary approach in the management of
ALS has been shown to provide superior care to de-
volved care, with better survival [7], improved qual-
ity of care, and quality of life. Access to expert
multidisciplinary management should be a standard
for patients with ALS [4, 10].
ALS Diagnosis
Delays of up to 12 months from the time of first
symptoms to diagnosis of ALS have been reported [5].
Andersen et al. [4], report the mean time from the
onset of symptoms to confirmation of the diagnosis of
ALS of 10–18 months. In England and Wales, Househam
and Swash [11], found the mean time from onset of symp-
toms to diagnosis was 16.2 months, while Donaghy et al.,
[12] identified a median time 15.6 months from first symp-
toms to diagnosis in Northern Ireland. A review of diagno-
sis timelines for patients with ALS over a 20 year period at
one treatment centre in the United Kingdom found that
the time from the first symptoms experienced by an
individual to a definite diagnosis of ALS had remained rela-
tively stable at approximately 12 months [13].
Diagnostic delays are associated with clinical com-
plexity, the patient either not recognizing or denying
early or intermittent symptoms, inefficient referral
pathways, with patients not being referred to special-
ist physicians, or being referred to a specialist other
than a neurologist/ALS specialist, and the relative rar-
ity and the consequent lack of familiarity with the
condition [4, 13, 14]. However, as the disease follows
a generally predictable duration from first symptoms
to death, such delays represent a significant propor-
tion of the total disease pathway. Early diagnosis has
implications for psychological outcomes for patients
and their families, for quality of life and service
utilization [13, 15]. It reduces the necessity for mul-
tiple referrals through the healthcare system in search
of a definitive diagnosis, and facilitates future plan-
ning and the introduction of Riluzole therapy,
currently the only available disease-modifying therapy
[4, 16]. The diagnosis story has been described as a
sequence of: recognising a problem, seeking medical
help, referrals to a series of health professionals, and
confirmation of ALS diagnosis [14].
Methods
During a clinical consultation, the medical history is
taken through a semi-structured interview, which has a
number of components including presenting complaint,
past medical history, current medications, family history,
social history, and systems review. Physical examination
is also structured by system.This narrative is transcribed
into a letter, and sent back to the referring person, and
copied to the general practitioner (if they are not the
referring doctor), and the patient’s chart.
As part of this study, medical interviews and medical
charts for 35 patients who were initial attenders at the
MDC were reviewed. These patients had either been
previously diagnosed elsewhere or had a confirmation
of their diagnosis of ALS on the occasion of this first
consultation with the specialist neurologist at the
National ALS Centre. Ethical approval was received
from Beaumont Hospital Medical Research Ethics
Committee review board.
Components of the patient journey derived from a
content analysis of the medical interviews, were incor-
porated into a template. Further data were collected
by systematic review of medical charts and by elabor-
ation of the journey using ancillary documentation
including nursing notes and those generated by clin-
ical professionals.
A template (Fig. 1) was designed to collect basic
patient information such as administrative identifiers,
sex and date of birth. The patient journey itself was
documented under a number of headings: first symp-
toms, site of onset, date of first visit to general practi-
tioner (GP) regarding symptoms, referrals to health
care professionals (HCP), interventions or tests per-
formed at each referral destination, date of diagnosis,
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the initial visit to MDC and related actions and rec-
ommendations. The medical charts for this cohort
were reviewed for data to populate the timeline tem-
plate. This was a sequential and iterative process as
the data collected in one phase contributed to the data
collected in another i.e. components of the patient
journey derived from a content analysis of medical
interviews, informed the design of the data collection
template which subsequently documented the patient
journey with data from the medical chart review. The
site for this study is a single clinic, at the National
ALS Centre at Beaumont Hospital Dublin. A consecu-
tive sample of thirty five new patients presenting with
a diagnosis of ALS during a 6 month period in 2013
were included in this analysis.
Results
From the medical interviews we identified components
of the patient’s journey to the MDC. The patient and
caregiver/family present described when s/he first
started feeling unwell, often noticing symptoms that
appeared unrelated while doing ordinary tasks; and
sometimes no action was taken as there was no immedi-
ate concern. The family member often noted symptoms
independently of the patient, encouraging him/her to
seek medical advice. The first contact with the health
Fig. 1 Data Collection Template: chart review – Timeline to Multidisciplinary Clinic
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services regarding symptoms was most often with a gen-
eral practitioner, and then a referral journey began from
one health care professional to another, from generalist
to specialist, involving a range of tests and interventions.
Findings from the chart review indicate that on first
attendance at the MDC the mean age for this group of
35 patients was 64 years (range 38.7 to 75.9), 51 % were
male, and 63 % had spinal onset. 51 % of patients were
diagnosed as ‘definite’ for ALS according to the El
Escorial criteria (Table 1).
Patient journey
Timeline
The patient journey from first symptoms, contact with
health services, ALS diagnosis and the initial visit to the
MDC at Beaumont Hospital is illustrated in Fig. 2 below.
There was an average of 5.5 months (median 3 months)
between the first symptom and visiting a GP; a mean of
11.2 months (median 8) from the first symptom to con-
tact with Neurology services, and 16 months (median
13) to ALS diagnosis, with over one and a half years
(mean 19.1 months, median 14.6) from the first symp-
tom to first visit to the multidisciplinary clinic.
Health service contact
From the information recorded, 91 % of patients (n = 32)
had contact with a general practitioner before embarking
on the subsequent referral pathway to the MDC. For this
cohort of patients the time from first GP visit to attend-
ing the MDC took an average of 13 months, (median
10.5). All patients had at least two contacts with health
care professionals before attending the MDC, with the
vast majority having multiple contacts (mean 3.97; me-
dian 3) (Fig. 3).
For this group of patients overall there were 139 re-
corded contacts with health care professionals. The ma-
jority (94 %) had contact with some Neurology service
(e.g. neurology, neurophysiology, neurosurgery) before
attending the MDC, 15 attended Neurology services as a
second contact with the health service , 17 as a third
contact and so on. 34 % had been to hospital or Acci-
dent and Emergency (A&E), and 17 % attended ortho-
paedic and physiotherapy services respectively (Table 2).
Over the course of these visits to health care profes-
sionals there was an average of 4.8 investigations and
tests carried out. Neurophysiology and Radiology investi-
gations were the most common (Table 3).
The patient journey from first contact with the health
services up to initial visit to the multidisciplinary clinic,
including numbers of contacts with each service, is illus-
trated in diagrammatic form in (Appendix 1). A sche-
matic representation of the sequence of health service
contacts up to the initial visit to the MDC, and the time
taken (in months) from first contact with the health ser-
vices and the multidisciplinary clinic is shown in
(Appendix 2).
First visit to MDC
During the first visit to MDC, these patients were seen
by the Consultant Neurologist and Clinical Nurse Spe-
cialist and subsequently by other members of the multi-
disciplinary team as appropriate to their condition. Oc-
cupational Therapy and Physiotherapy were the services
used most frequently during this initial visit (Fig. 4). At
the Clinic patients received treatment and advice from
allied health professionals, with links made with health
and social care services in the community and voluntary
sector as required.
Discussion
The personal relationship between the patient and phys-
ician remains the basis of high quality treatment [17].
Illness, and the process of being ill, is formed and articu-
lated in the physician-patient encounter. The patient’s
experience of symptoms is interpreted by physician’s
medical knowledge, leading to a diagnosis, and a corre-
sponding therapeutic intervention [18]. Physicians must
know the facts of pathophysiology but also the individual
patient and the symptoms, signs and answers to ques-
tions that fill out the story of the illness presented to
him/her for medical attention. The interpretive reason-
ing required to understand signs and symptoms and to
reach a diagnosis is represented in its situated and
circumstantial uncertainty in narrative [19].
The pre-diagnostic phase has been described as a
‘diagnostic roundabout’ [13], characterized by uncer-
tainty and traumatic experiences. From the chart review
we identified that the majority of this cohort of patients
(91 %) attended a GP as their first contact with the
health services. We have identified an average of four
contacts with health services (with a maximum of 7
Table 1 Patient details
Age Mean (years) 64.3
Range 38.7 - 75.9
N (%)
Sex Male 18 (51.4 %)
Female 17 (48.6 %)
Site of Onset Bulbar 8 (22.9 %)
Bulbar/cognitive 2 (5.7 %)
Spinal 22 (62.9 %)
Spinal/cognitive 3 (8.6 %)
El Escorial Definite 18 (51.4 %)
Possible 5 (14.3 %)
Probable 10 (28.6 %)
Not Stated 2 (5.7 %)
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contacts) and 4.8 investigations/tests, prior to the first
MDC visit. Neurophysiology and Radiology investiga-
tions were the most frequently performed.
The time from first symptom to diagnosis was a mean
of 16 months (median 13 months). This may reflect
delayed referral for specialist investigations, and patients
being initially directed to specialities other than neur-
ology such as physiotherapy, orthopaedics, or to staff in
local general hospitals which may not have recognised
the underlying neurological problems. Overall, this led
to a mean delay of 11.2 months (median 8) from first
symptom to contact with Neurology services. The time
from first GP visit to attending the MDC took an aver-
age of 13 months, (median 10.5 months). The timeline
constructed shows a mean interval of 19 months
(median 14.6) from first symptoms to arrival at the spe-
cialist MDC. The Patient Journey (Appendix 1 and 2)
identifies the sequence of health service contacts, and
the journey over many months, which patients travelled
before the MDC. Patients and their families began their
engagement with the multidisciplinary team at their first
clinic visit, with a majority being seen by Occupational
Therapy and Physiotherapy, and others making contact
with Speech and Language Therapy, Dietician and
Neuropsychology.
Few studies have employed qualitative approaches to
explore the diagnostic experience from the perspective
of patients and their carers [14]. As part of a longitu-
dinal study at the National ALS Centre in Dublin,
following the patient and caregiver journey, informal
caregivers of people with ALS were asked about the time
up to the ALS diagnosis and what it was like for the
caregiver. A preliminary thematic analysis [20] of their
responses provides an insight into the journey to the
MDC, as a series of seemingly unrelated symptoms went
unrecognised, with subsequent differential diagnosis by
Fig. 3 Contacts with Healthcare Professionals
Fig. 2 Timeline –First Symptom Timeline
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health professionals. The caregivers recounted stages on
the referral journey, as one commented “we first went to
the physiotherapist, then the neurologist about her
migraines”, and for another “the doctors … as a last re-
sort they sent us to a speech and language therapist and
the speech and language therapist referred us to a
consultant neurologist.” For some it seems that health-
related information was revealed through less than opti-
mal communication with the HCPs, and according to
one caregiver “the way the doctor told us was not great.
Doctor left us and thought we would ask lots of questions
and we didn’t ask anything”.
The medical interview is a version of events as re-
membered and recounted by the patient and his/her
family, mediated by the health care practitioner. This
account is reflected in the medical interview/letter and
presented in a particular format. It is important to bear
in mind the positionality of the patient-caregiver and
physician in a power-knowledge-practice complex; and
also to consider the social rules of engagement and
interaction, the social location of the patient and family
member, time constraints, and that the illness narrative
can be both formed and changed by the medical en-
counter (co-creation). Nonetheless, the medical inter-
view provides valuable insight into the crucial journey of
the patient and caregiver to their initial visit to the
MDC, highlighting contacts with the health services and
timelines on the journey. A review of the medical charts
for these patients generated fine-grained information
from which detailed schematic and individual patient
journeys were constructed.
The use of multiple data sources in this analysis -
medical interviews and systematic chart review - allowed
for cross-checking of information in an iterative process
for clarification of details as required. The interviews
recorded information in narrative form and exact dates
were not always included, while the medical charts con-
tained comprehensive information which was often
‘fleshed out’ by going back to the medical interview data
for corroboration and/or context.
Through the process of this study gaps in data record-
ing were encountered. During the initial medical inter-
view it is understandable that patient and caregiver/
family might not clearly recall detailed information and
dates, names or clinical specialties of practitioners whom
they encountered, or precise tests and investigations.
The precise noting of dates of referrals and tests, in a
busy clinical situation is not always possible. For ac-
curate analysis of the patient journey it is important
to record detailed and specific information and to
generate robust data for health services research. This
study has contributed to highlighting the implications
of data recording for clinical management leading to
the development of a systematic recording and data
collection framework.
Access to multidisciplinary care should be the stand-
ard for all ALS patients. Our findings suggest a mean of
19 months from first symptom to the initial visit to the
Clinic, during which time the patient attends a variety of
health care practitioners and undergoes tests and inves-
tigations as directed. The timelines on the journey from
noticing first symptoms and involvement with health
services to arrival at the MDC, can involve personal and
systemic factors. Patients may ignore or choose to deny
Table 3 Investigations Pre MDC
Investigation/Treatment Number




Admission/Contact to hospital 16
Bloods (incl. genetic test and thyroid level) 13
Treatment 10
Got opinion or referred to another speciality 8








Average investigations/treatments pre MDC 4.80
*EMG = Electromyography, NCS = Nerve Conduction Studies, MRI = Magnetic
Resonance Imaging, CT = Computed Tomography
Table 2 Sequence of contacts with health services
Contact sequence
Professional 1st 2nd 3rd 4th 5th 6th Total contacts
GP 32 1 33
A&E 2 1 3
Hospital 1 3 4 2 2 12
Neuro 15 17 11 8 5 56
Rheumatology 2 2
ENT* 2 1 3
Other Surgical 1 1 1 3
Physiotherapy 1 4 1 6
Orthopaedic 5 2 1 8
Geriatrician 2 1 1 4
Chiropractor 1 1 2
Other** 1 1 4 1 7
*ENT = Ear Nose and Throat
**e.g. psychiatrist, pain specialist, radiologist
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symptoms, and postpone engagement with health care
professionals, while obstacles within the health system
such as shortages in essential staff, poor access to inves-
tigations, limited knowledge of the condition and a fail-
ure to recognize the benefits of the MDC can affect the
trajectory of the subsequent journey to the MDC. While
earlier diagnosis could avoid unnecessary referrals and
facilitate future planning, this is not always feasible. ALS
is relatively rare and most general practitioners have
limited experience of the condition. Our data illustrate
that interaction with the general practitioner is a com-
mon first point of engagement with the health services.
A “red flag” guideline has been established for general
practitioners in the UK, the aim of which is to expedite
referral for differential diagnosis [21]. Timely referral to
the specialist MDC for those with suspected disease is
also essential. Our data would suggest that utilization
of unnecessary investigations, and an apparent reluc-
tance by non-specialists to make a definitive diagnosis
may also delay referral to MDC. Further work using
larger patient cohorts will be required to confirm these
observations.
This is a small scale study referencing a single special-
ist clinic. Nevertheless, this exploratory study has identi-
fied the importance of comprehensive data collection
and the utility of multiple data sources, for the elucida-
tion of touch-points, timelines and identification of the
patient journey. Additional information, for example, on
patient’s distance from the MDC, socio-economic char-
acteristics and progress of the condition and a larger
sample size will allow for the exploration of trends and
associations within the data.
Conclusion
This exploratory multi-method study details the patient
journey to a specialist ALS Multidisciplinary Clinic
(MDC). On the first visit to the MDC, patients are
linked into an integrated system comprising expertise
in neurology, specialist nursing, respiratory medicine,
physiotherapy, occupational therapy neuropsychology
and palliative care that can provide specialist care and
link with voluntary, palliative and community services
as required.
In ALS the precise patient journey from first symptom
to diagnosis to death and the economic costs of disease
management have not yet been fully mapped. The no-
tion of a pathway conveys the idea of a linear progres-
sion albeit one that can split off in a number of
directions. The concept of a journey is preferred here
and captures an impression as outlined in the patient
narratives as something that is embarked upon without
a known destination in mind. This analysis has tracked
the patient journey to the Multidisciplinary Clinic at the
National ALS Centre in Dublin. Engagement with a
multidisciplinary team has implications for service
utilization and quality of life of patients and their fam-
ilies. Detailed analysis of the patient journey is urgently
required by following the journeys of people in real time
from the point of diagnosis, and by retrospective collec-
tion of experiences prior to diagnosis. This method can
generate a comprehensive map of the interplay between
the patient/caregiver dyad with the health services, and
in doing so can formulate a coherent set of guidelines
that will facilitate early access to specialist services.
Appendix 1
Patient Journey from first contact with health services to
MDC – (numbers indicate contacts with each service)
Appendix 2
Schematic representation of Patient Journey to MDC
(duration in months from recorded first health service
contact to MDC)
Abbreviations
A&E: accident and emergency; ALS: amyotrophic lateral sclerosis;
CT: computed tomography; EMG: electromyography; ENT: ear nose and
Fig. 4 MDT – Service Usage
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throat; GP: general practitioner; HCP: Health Care Professionals;
MDC: multidisciplinary clinic; MDT: Multidisciplinary Team; MRI: magnetic
resonance imaging; NCS: nerve conduction studies.
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